DJIA 16,614.81 0.00 0.00%
NASDAQ 4,419.48 0.00 0.00%
S&P 500 1,941.28 0.00 0.00%
market minute promo

Epizyme (NASDAQ: EPZM)

27.62 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

EPZM $27.62 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.88
Previous Close $27.62
Daily Range $27.15 - $28.25
52-Week Range $18.10 - $42.00
Market Cap $927.6M
P/E Ratio 28.44
Dividend (Yield) $0.00 (0.0%)
Volume 195,947
Average Daily Volume 325,323
Current FY EPS -$1.68

Sector

Industry

Epizyme (EPZM) Description

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. Website: http://www.epizyme.com/

News & Commentary

Why Epizyme Inc. Shares Rocketed Higher

Epizyme shares soar after the company reaches another creative milestone with partner GlaxoSmithKline.

What Falling Estimates & Price Mean for Enzo Biochem (ENZ) - Tale of the Tape

Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4% - Tale of the Tape

Alnylam Pharmaceuticals (ALNY) Jumps: Stock Rises 19% - Tale of the Tape

Epizyme Announces Clinical And Pre-Clinical Data To Be Featured In Oral And Poster Presentations At

Epizyme Announces Clinical And Pre-Clinical Data To Be Featured In Oral And Poster Presentations At American Society Of Hematology (ASH) Annual Meeting

Commit To Purchase Epizyme At $22.50, Earn 19.4% Annualized Using Options

Epizyme (EPZM) Downgraded From Hold to Sell

UPDATE: Mizuho Securities USA Initiates Coverage On Epizyme Inc On Epigenetics Pure Play

Benzinga's Top Initiations

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Epizyme Announces Resignation Of President And CFO Jason Rhodes

See More EPZM News...